Why Did Netflix Buy Warner Bros?
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
Sell
42
AONC Quote, Financials, Valuation and Earnings
Last price:
$11.12
Seasonality move
:
-1.35%
Day range:
$11.12 - $11.12
52-week range:
$4.04 - $14.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.13x
P/B ratio:
--
Volume:
105
Avg. volume:
1.7K
1-year change:
155.63%
Market cap:
$325.2M
Revenue:
$1.8B
EPS (TTM):
-$2.27
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AONC
American Oncology Network, Inc.
|
-- | -- | -- | -- | -- |
|
EHC
Encompass Health Corp.
|
$1.5B | $1.19 | 9.65% | 10.17% | $140.33 |
|
MD
Pediatrix Medical Group, Inc.
|
$476.4M | $0.47 | -3.21% | 51.56% | $22.67 |
|
NAKA
Kindly MD, Inc.
|
$400.2K | -$0.01 | -34.74% | -94.11% | $1.25 |
|
SRXH
SRx Health Solutions, Inc.
|
-- | -- | -- | -- | -- |
|
TOI
The Oncology Institute, Inc.
|
$122.6M | -$0.10 | 39.41% | -52.63% | $6.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AONC
American Oncology Network, Inc.
|
$11.12 | -- | $325.2M | -- | $0.00 | 0% | 0.13x |
|
EHC
Encompass Health Corp.
|
$111.91 | $140.33 | $11.3B | 21.15x | $0.19 | 0.63% | 1.97x |
|
MD
Pediatrix Medical Group, Inc.
|
$21.57 | $22.67 | $1.9B | 11.39x | $0.00 | 0% | 0.96x |
|
NAKA
Kindly MD, Inc.
|
$0.45 | $1.25 | $3.4M | -- | $0.00 | 0% | 12.67x |
|
SRXH
SRx Health Solutions, Inc.
|
$0.46 | -- | $11.3M | 0.14x | $0.00 | 0% | 0.08x |
|
TOI
The Oncology Institute, Inc.
|
$3.18 | $6.50 | $312.9M | -- | $0.00 | 0% | 0.59x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AONC
American Oncology Network, Inc.
|
173.84% | 2.072 | 43.66% | 1.06x |
|
EHC
Encompass Health Corp.
|
52.86% | 0.219 | 19.56% | 0.97x |
|
MD
Pediatrix Medical Group, Inc.
|
41.9% | 0.826 | 44.67% | 1.77x |
|
NAKA
Kindly MD, Inc.
|
29.88% | 41.625 | 2500.93% | 0.11x |
|
SRXH
SRx Health Solutions, Inc.
|
13.36% | -4.480 | -- | 1.30x |
|
TOI
The Oncology Institute, Inc.
|
113.45% | -2.011 | 30.41% | 1.33x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AONC
American Oncology Network, Inc.
|
$36.5M | $1.8M | -6% | -13.79% | 0.07% | -$34.5M |
|
EHC
Encompass Health Corp.
|
$299.7M | $243.6M | 12.69% | 24.34% | 16.49% | $83.7M |
|
MD
Pediatrix Medical Group, Inc.
|
$134.8M | $74M | 11.1% | 20.22% | 15.02% | $131.9M |
|
NAKA
Kindly MD, Inc.
|
-$6.1M | -$10.4M | -64.63% | -91.57% | -2680.45% | -$692.1M |
|
SRXH
SRx Health Solutions, Inc.
|
$2.4M | -$1.1M | -- | -- | -15.2% | $377K |
|
TOI
The Oncology Institute, Inc.
|
$17.2M | -$8.1M | -48.97% | -9486.64% | -5.9% | -$13.2M |
American Oncology Network, Inc. vs. Competitors
-
Which has Higher Returns AONC or EHC?
Encompass Health Corp. has a net margin of -0.23% compared to American Oncology Network, Inc.'s net margin of 11.82%. American Oncology Network, Inc.'s return on equity of -13.79% beat Encompass Health Corp.'s return on equity of 24.34%.
Company Gross Margin Earnings Per Share Invested Capital AONCAmerican Oncology Network, Inc.7.77% -$0.19 $145.5M EHCEncompass Health Corp.20.28% $1.24 $5.8B -
What do Analysts Say About AONC or EHC?
American Oncology Network, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Encompass Health Corp. has an analysts' consensus of $140.33 which suggests that it could grow by 25.4%. Given that Encompass Health Corp. has higher upside potential than American Oncology Network, Inc., analysts believe Encompass Health Corp. is more attractive than American Oncology Network, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AONCAmerican Oncology Network, Inc.0 0 0 EHCEncompass Health Corp.11 0 0 -
Is AONC or EHC More Risky?
American Oncology Network, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Encompass Health Corp. has a beta of 0.746, suggesting its less volatile than the S&P 500 by 25.418%.
-
Which is a Better Dividend Stock AONC or EHC?
American Oncology Network, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Encompass Health Corp. offers a yield of 0.63% to investors and pays a quarterly dividend of $0.19 per share. American Oncology Network, Inc. pays -- of its earnings as a dividend. Encompass Health Corp. pays out 14.35% of its earnings as a dividend. Encompass Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AONC or EHC?
American Oncology Network, Inc. quarterly revenues are $470.3M, which are smaller than Encompass Health Corp. quarterly revenues of $1.5B. American Oncology Network, Inc.'s net income of -$1.1M is lower than Encompass Health Corp.'s net income of $174.7M. Notably, American Oncology Network, Inc.'s price-to-earnings ratio is -- while Encompass Health Corp.'s PE ratio is 21.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Oncology Network, Inc. is 0.13x versus 1.97x for Encompass Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AONCAmerican Oncology Network, Inc.0.13x -- $470.3M -$1.1M EHCEncompass Health Corp.1.97x 21.15x $1.5B $174.7M
-
Which has Higher Returns AONC or MD?
Pediatrix Medical Group, Inc. has a net margin of -0.23% compared to American Oncology Network, Inc.'s net margin of 14.55%. American Oncology Network, Inc.'s return on equity of -13.79% beat Pediatrix Medical Group, Inc.'s return on equity of 20.22%.
Company Gross Margin Earnings Per Share Invested Capital AONCAmerican Oncology Network, Inc.7.77% -$0.19 $145.5M MDPediatrix Medical Group, Inc.27.35% $0.84 $1.5B -
What do Analysts Say About AONC or MD?
American Oncology Network, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Pediatrix Medical Group, Inc. has an analysts' consensus of $22.67 which suggests that it could grow by 5.08%. Given that Pediatrix Medical Group, Inc. has higher upside potential than American Oncology Network, Inc., analysts believe Pediatrix Medical Group, Inc. is more attractive than American Oncology Network, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AONCAmerican Oncology Network, Inc.0 0 0 MDPediatrix Medical Group, Inc.2 5 0 -
Is AONC or MD More Risky?
American Oncology Network, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pediatrix Medical Group, Inc. has a beta of 0.766, suggesting its less volatile than the S&P 500 by 23.447%.
-
Which is a Better Dividend Stock AONC or MD?
American Oncology Network, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pediatrix Medical Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Oncology Network, Inc. pays -- of its earnings as a dividend. Pediatrix Medical Group, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AONC or MD?
American Oncology Network, Inc. quarterly revenues are $470.3M, which are smaller than Pediatrix Medical Group, Inc. quarterly revenues of $492.9M. American Oncology Network, Inc.'s net income of -$1.1M is lower than Pediatrix Medical Group, Inc.'s net income of $71.7M. Notably, American Oncology Network, Inc.'s price-to-earnings ratio is -- while Pediatrix Medical Group, Inc.'s PE ratio is 11.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Oncology Network, Inc. is 0.13x versus 0.96x for Pediatrix Medical Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AONCAmerican Oncology Network, Inc.0.13x -- $470.3M -$1.1M MDPediatrix Medical Group, Inc.0.96x 11.39x $492.9M $71.7M
-
Which has Higher Returns AONC or NAKA?
Kindly MD, Inc. has a net margin of -0.23% compared to American Oncology Network, Inc.'s net margin of -22162.75%. American Oncology Network, Inc.'s return on equity of -13.79% beat Kindly MD, Inc.'s return on equity of -91.57%.
Company Gross Margin Earnings Per Share Invested Capital AONCAmerican Oncology Network, Inc.7.77% -$0.19 $145.5M NAKAKindly MD, Inc.-1565.61% -$0.42 $681.1M -
What do Analysts Say About AONC or NAKA?
American Oncology Network, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Kindly MD, Inc. has an analysts' consensus of $1.25 which suggests that it could grow by 176.37%. Given that Kindly MD, Inc. has higher upside potential than American Oncology Network, Inc., analysts believe Kindly MD, Inc. is more attractive than American Oncology Network, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AONCAmerican Oncology Network, Inc.0 0 0 NAKAKindly MD, Inc.1 0 0 -
Is AONC or NAKA More Risky?
American Oncology Network, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Kindly MD, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AONC or NAKA?
American Oncology Network, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kindly MD, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Oncology Network, Inc. pays -- of its earnings as a dividend. Kindly MD, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AONC or NAKA?
American Oncology Network, Inc. quarterly revenues are $470.3M, which are larger than Kindly MD, Inc. quarterly revenues of $388.2K. American Oncology Network, Inc.'s net income of -$1.1M is higher than Kindly MD, Inc.'s net income of -$86M. Notably, American Oncology Network, Inc.'s price-to-earnings ratio is -- while Kindly MD, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Oncology Network, Inc. is 0.13x versus 12.67x for Kindly MD, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AONCAmerican Oncology Network, Inc.0.13x -- $470.3M -$1.1M NAKAKindly MD, Inc.12.67x -- $388.2K -$86M
-
Which has Higher Returns AONC or SRXH?
SRx Health Solutions, Inc. has a net margin of -0.23% compared to American Oncology Network, Inc.'s net margin of -13.47%. American Oncology Network, Inc.'s return on equity of -13.79% beat SRx Health Solutions, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AONCAmerican Oncology Network, Inc.7.77% -$0.19 $145.5M SRXHSRx Health Solutions, Inc.33.29% -$0.07 $9.2M -
What do Analysts Say About AONC or SRXH?
American Oncology Network, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand SRx Health Solutions, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that American Oncology Network, Inc. has higher upside potential than SRx Health Solutions, Inc., analysts believe American Oncology Network, Inc. is more attractive than SRx Health Solutions, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AONCAmerican Oncology Network, Inc.0 0 0 SRXHSRx Health Solutions, Inc.0 0 0 -
Is AONC or SRXH More Risky?
American Oncology Network, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SRx Health Solutions, Inc. has a beta of 0.929, suggesting its less volatile than the S&P 500 by 7.069%.
-
Which is a Better Dividend Stock AONC or SRXH?
American Oncology Network, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SRx Health Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Oncology Network, Inc. pays -- of its earnings as a dividend. SRx Health Solutions, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AONC or SRXH?
American Oncology Network, Inc. quarterly revenues are $470.3M, which are larger than SRx Health Solutions, Inc. quarterly revenues of $7.2M. American Oncology Network, Inc.'s net income of -$1.1M is lower than SRx Health Solutions, Inc.'s net income of -$964K. Notably, American Oncology Network, Inc.'s price-to-earnings ratio is -- while SRx Health Solutions, Inc.'s PE ratio is 0.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Oncology Network, Inc. is 0.13x versus 0.08x for SRx Health Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AONCAmerican Oncology Network, Inc.0.13x -- $470.3M -$1.1M SRXHSRx Health Solutions, Inc.0.08x 0.14x $7.2M -$964K
-
Which has Higher Returns AONC or TOI?
The Oncology Institute, Inc. has a net margin of -0.23% compared to American Oncology Network, Inc.'s net margin of -10.08%. American Oncology Network, Inc.'s return on equity of -13.79% beat The Oncology Institute, Inc.'s return on equity of -9486.64%.
Company Gross Margin Earnings Per Share Invested Capital AONCAmerican Oncology Network, Inc.7.77% -$0.19 $145.5M TOIThe Oncology Institute, Inc.12.59% -$0.14 $91.3M -
What do Analysts Say About AONC or TOI?
American Oncology Network, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand The Oncology Institute, Inc. has an analysts' consensus of $6.50 which suggests that it could grow by 104.4%. Given that The Oncology Institute, Inc. has higher upside potential than American Oncology Network, Inc., analysts believe The Oncology Institute, Inc. is more attractive than American Oncology Network, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AONCAmerican Oncology Network, Inc.0 0 0 TOIThe Oncology Institute, Inc.3 0 0 -
Is AONC or TOI More Risky?
American Oncology Network, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Oncology Institute, Inc. has a beta of 0.162, suggesting its less volatile than the S&P 500 by 83.817%.
-
Which is a Better Dividend Stock AONC or TOI?
American Oncology Network, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Oncology Institute, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Oncology Network, Inc. pays -- of its earnings as a dividend. The Oncology Institute, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AONC or TOI?
American Oncology Network, Inc. quarterly revenues are $470.3M, which are larger than The Oncology Institute, Inc. quarterly revenues of $136.6M. American Oncology Network, Inc.'s net income of -$1.1M is higher than The Oncology Institute, Inc.'s net income of -$13.8M. Notably, American Oncology Network, Inc.'s price-to-earnings ratio is -- while The Oncology Institute, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Oncology Network, Inc. is 0.13x versus 0.59x for The Oncology Institute, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AONCAmerican Oncology Network, Inc.0.13x -- $470.3M -$1.1M TOIThe Oncology Institute, Inc.0.59x -- $136.6M -$13.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
67
GPCR alert for Dec 9
Structure Therapeutics, Inc. [GPCR] is up 102.52% over the past day.
Buy
62
SMX alert for Dec 9
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Buy
90
KYMR alert for Dec 9
Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.
